Prestige Consumer Healthcare Inc - רווח נקי למניה אחת בשנים עשר החודשים האחרונים PBH

The defensive status of the business and the pricing power of Prestige Consumer Healthcare (PBH) combine with a mature portfolio of hygiene and self-care products. The annual EPS growth rate over the last 12 months visualizes this trend, where -20.10 forms the current metric. This results in an effective asset-light strategy for managing the logistics and marketing of the iconic Clear Eyes and Compound W brands.
Prestige Corp - פילוחים אנליטיים ומדדי מפתח (PBH)

Steady demand for Prestige Consumer Healthcare (PBH) medications offsets geopolitical risks, although the vulnerability of Asian raw material supply chains directly impacts profitability. By analyzing the rolling annual EPS change, an investor assesses the growth rate of net income per share over 12 months, which allows them to filter out market volatility and determine the fundamental stability of this defensive asset.